Symmetry Medical Reports Second Quarter 2010 Financial Results

WARSAW, Ind., Aug. 5 /PRNewswire-FirstCall/ -- Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced second quarter 2010 financial results for the three-month period ended July 3, 2010.

Revenue for the second quarter 2010 was $88.8 million, up 5.1% on a sequential basis from the $84.5 million reported in the first quarter 2010, reflecting increased customer demand in the Company's orthopedic and medical device businesses. Revenue for the second quarter 2009 was $101.0 million.  

Gross profit for the second quarter 2010 was $20.4 million, up 19.5% on a sequential basis from the $17.0 million reported in the first quarter 2010 and compared to $26.8 million in the second quarter 2009.  Gross margin percentage for the second quarter 2010 was 22.9% compared to 20.2% for the first quarter 2010 and 26.5% in the same period last year.

Selling, general and administrative expenses in the second quarter 2010 were $12.3 million, a decrease of 2.6% on sequential basis from $12.6 million in the first quarter 2010 as a result of lower sales and marketing expenses due to the timing of industry trade shows during the first quarter 2010.  Expenses were down 6.9% compared to $13.2 million in the second quarter 2009.  The year-over-year decrease was driven primarily by cost controls implemented during the second half of 2009.

On a pre-tax basis, facility closure and severance costs were $0.3 million in the second quarter of 2010, compared to $0.5 million in the first quarter of 2010 and $0.1 million in the second quarter of 2009.

Operating income for the second quarter 2010 was $7.8 million, up from first quarter 2010 operating income of $3.9 million and compared to $13.5 million for the second quarter 2009. Operating margin for the second quarter 2010 was 8.7%, compared to 4.6% in the first quarter 2010 and 13.4% for the second quarter 2009. Excluding expenses related to facility consolidation and employee severance payments referenced above, operating income for the second quarter 2010 was $8.1 million compared to $4.4 million in the first quarter of 2010.

The second quarter 2010 included a non-cash gain of $0.5 million for the mark to market of the Company's interest rate derivative, compared to a non-cash gain for the interest rate derivative of $0.2 million in the second quarter 2009.  

Income tax expense for the second quarter 2010 was $2.4 million, compared to a tax expense of $3.2 million for the second quarter of 2009.

Net income for the second quarter 2010 was $4.5 million, or $0.13 per diluted share, up from $1.6 million, or $0.05 per diluted share, for the first quarter of 2010 and compared to $9.0 million, or $0.25 per diluted share, for the second quarter of 2009. Excluding the facility consolidation and employee severance payments referenced above, net income for the second quarter 2010 was $4.7 million, or $0.14 per diluted share compared to $0.06 per diluted share in the first quarter of 2010.

The weighted average number of diluted shares outstanding during the second quarter of 2010 was 35,806,676.

Brian Moore, President and Chief Executive Officer of Symmetry Medical, stated, "Total revenue in second quarter 2010 grew by five percent sequentially, providing further evidence of a stabilized and improving environment. We also achieved sequential expansion of gross margin and operating margin during the quarter, demonstrating better operational efficiency as we adjust to higher volume. Together, these positive results give us confidence that we are well positioned to benefit from a reacceleration of growth and to meet our 2010 revenue and EPS guidance."

Financial Guidance

The following forward-looking estimates regarding 2010 guidance reflect current market conditions and foreign currency rates. Actual results may differ materially, and the Company refers you to forward-looking statements located at the end of the press release.  

For the full year 2010, the Company is increasing revenue guidance to a range of $340 million to $350 million, up from the previously announced range of $330 million to $340 million. The increase is based on the Company's actual results for the first half of 2010, current inventory levels and expected customer product launch activity, and expected positive impact from foreign exchange rates in the second half of 2010. For the full year 2010, the Company is reiterating its earnings per share guidance of a range of $0.45 to $0.50.  

Conference Call

Symmetry Medical will host a conference call to discuss second quarter 2010 financial results at 8:00 a.m. ET on August 5, 2010. A live Web cast of the conference call will be available online from the investor relations page of the Company's corporate Web site at www.symmetrymedical.com. The dial-in numbers are (866) 356-3093 for domestic callers and (617) 597-5381 for international. The reservation number for both is 23553266. After the live Web cast, the call will remain available on Symmetry Medical's Web site through November 5, 2010. In addition, a telephonic replay of the call will be available until August 19, 2010. The replay numbers are (888) 286-8010 for domestic callers and (617) 801-6888 for international callers. Please use reservation code 34068334.

About Symmetry Medical Inc.

Symmetry Medical Inc. is a leading independent provider of implants and related instruments and cases to the orthopaedic device industry. The Company also designs, develops and produces these products for companies in other segments of the medical device market, including arthroscopy, dental, laparoscopy, osteobiologic and endoscopy sectors and provides limited specialized products and services to non-healthcare markets, such as the aerospace market.

Non-GAAP Measures

The non-GAAP measures, including adjusted operating income, net income and EPS, shown in this release exclude facility consolidation and severance costs.  Reconciliations of these non-GAAP measures to the most directly comparable GAAP measure are included after the financial information included in this press release.  These measures are not in accordance with, or an alternative for, GAAP and may be different from non-GAAP measures used by other companies.  Management believes these non-GAAP measures improve management's and investors' the ability to better compare the company's ongoing financial performance between periods and with other companies.

Forward-Looking Statements

Statements in the press release regarding Symmetry Medical Inc.'s business which are not historical facts may be "forward-looking statements" that involve risks and uncertainties, within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are predictive in nature and are frequently identified by the use of terms such as "may," "might," "will," "should," "expect," "believe," "anticipate," "plan," "estimate," "intend," and similar words indicating possible future expectations, events or actions. Such predictive statements are not guarantees of future performance, and actual outcomes and results could differ materially from our current expectations. We refer you to the "Risk Factors" and "Forward Looking-Statements" sections in the Company's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission as well as the Company's other filings with the SEC, which are available on the SEC's Web site at www.sec.gov.

SOURCE Symmetry Medical Inc.